期刊文献+

钆双胺对^99Tc^m—MDP骨显像影响的实验研究

Experimental study of the influence of Omniscan on ^99Tc^m-MDP bone imaging
原文传递
导出
摘要 目的探讨MRI对比剂钆双胺注射液(欧乃影;Gd—DTPA—BMA)应用后对家兔^99Tc^m-MDP骨显像的影响。方法采用自身前后对照方法,实验组(注射欧乃影+^99Tc^m-MDP)与自身对照组(注射生理盐水+^99Tc^m-MDP)处理相隔7d。(1)取家兔5只,注射欧乃影或生理盐水后30min注射^99Tc^m-MDP,并于注射^99Tc^m-MDP后5、10、30、60、120、180、240和360min、24h时行骨显像,勾画ROI,计算靶/本底(T/B)值,观察家兔显像剂分布及代谢情况。(2)取家兔30只,按欧乃影或生理盐水与^99Tc^m-MDP的注射间隔(30、60、120、240和360min、24h)分为6组,每组5只。均于注射^99Tc^m-MDP后120min行骨显像,勾画ROI,计算T/B值。(3)采用TLC测定2种药物相互作用后在体内的放化纯差异。以配对t检验进行统计分析。结果注射欧乃影后30min再注射^99Tc^m-MDP,5min时肝、脾开始显影,其T/B比值120min时达最高峰(肝、脾分别为4.56±0.32和3.56±0.41);而2组椎体24h时T/B值均达最大值(实验组为4.32±0.07,自身对照组为6.31±0.09),但各时间点实验组均较自身对照组低。两药物注射间隔为30、60、120和240min时,可出现肝、脾异常显影,对应的实验组T/B(肝:2.47~4.22;脾:1.85~3.23)明显高于自身对照组(肝:1.52—1.58;脾:1.25~1.29),但实验组椎体的T/B(3.08~4.28)则较自身对照组低(4.82~4.85),以上差异均有统计学意义(t=7.750—31.916,均P〈0.05)。余时间间隔组,肝、脾未见明显摄取^99Tc^m-MDP。TLC曲线示,实验组在Rf为0—0.2处形成小峰,^99Tc^m-MDP放化纯降为(63.51±2.24)%。结论注射欧乃影后短时间内行^99Tc^m-MDP骨显像,肝、脾会出现异常摄取;间隔360min再行^99Tc^m-MDP骨显像可避免此现象发生。 Objective To investigate the effects of MRI contrast agent Omniscan on ^99Tc^m-MDP bone imaging in rabbits. Methods Self-control method was used in this study: experimental group was in- jected with Omniscan + ^99Tc^m-MDP; control group was injected with normal saline + ^99Tc^m-MDP. The time interval between 2 experiments was 7 d. ( 1 ) Five rabbits were injected Omniscan/normal saline and ^99Tc^m-MDP with the time interval of 30 min. Whole body bone imaging was performed to observe the distribution and metabolism of ^99Tc^m-MDP in the two groups at 5, 10, 30, 60,120, 240, 360 min and 24 h after injection of ^99Tc^m-MDP. ROI was drawn and T/B was calculated. (2)Thirty rabbits were divided into 6 groups according to the different time intervals (30, 60, 120,240 and 360 min, 24 h) between injection of Omniscan/ normal saline and ^99Tc^m-MDP. Whole body bone imaging was performed in the 6 groups 2 h after injection of ^99Tc^m-MDP. ROI was drawn and T/B was calculated. (3)The radiochemical purity in vivo was investigated by TLC. Paired t test was used to analyze the data. Results ( 1 ) When the injection interval of Omniscan and ^99Tc^m-MDP was 30 min, the radioactive uptake by liver and spleen was shown at 5 min, and the T/B ratios were the highest at 2 h (4.56±0.32 and 3.56±0.41 for liver and spleen respectively). The T/B ratio of vertebra in experimental group was lower than that in control group at all time points and it reached the highest point at 24 h in both groups ((4.32±0.07) and (6.31±0.09) respectively). (2)When the injection interval was 30, 60, 120, 240 min, the liver and spleen were visualized. The T/B ratios of liver and spleen were higher in experimental groups ( liver: 2.47- 4.22; spleen : 1.85- 3.23 ) compared to those of the control group (liver: 1.52-1.58 ;spleen: 1.25-1.29) , and the T/B ratio of vertebra was lower in experimen- tal groups ( 3.08- 4.28 ) than that in control group ( 4.82 - 4.85 ; t = 7.750 - 31.916, all P〈 0.05 ). Radioactive uptake by the liver and spleen was not shown in other injection interval groups. The TLC curve showed a small peak at Rf of 0-0.2 in the experimental group and the radiochemical purity of ^99Tc^m-MDP decreased to (63.51±2.24) %. Conclusions When Omniscan is injected before ^99Tc^m-MDP, liver and spleen may show abnormal radioactive uptake on bone imaging. Taking 360 min as the injection interval may help to avoid it.
出处 《中华核医学与分子影像杂志》 CSCD 北大核心 2014年第3期226-230,共5页 Chinese Journal of Nuclear Medicine and Molecular Imaging
基金 四川省医学重点学科建设项目(2008-16)
关键词 骨骼 放射性核素显像 造影剂 MDP Skeleton Radionuclide imaging Contrast media MDP Rabbits
  • 相关文献

参考文献18

  • 1Abrams J, Tiu S. Reversal of drug-induced rhabdomyolysis on bone scan[J]. Clin Nucl Med, 2011, 36: e101-102.
  • 2Gontier E, Fourme E, Wartski M, et al. High and typical ^18F-FDG bowel uptake in patients treated with mefformin [ J ]. Eur J Nuel Med Mol Imaging, 2008, 35: 95-99.
  • 3Shi X, Jing H, Zhuang H, et al. Diffuse hepatic and splenic up- take of ^99Tc^m methylene diphosphonate on bone scintigraphy after intravenous administration of gadolinium-containing MRI contrast [J]. Clin Nucl Med, 2011, 36: 178-182.
  • 4Zhang W, Zhang Y, Li X, et al. Increased liver and spleen accu- mulation of ^99Tc^m methylene diphosphonate associated with intrave- nous injection of MRI contrast gadolinium-diethylenetriaminepenta- acetic acid[J]. Clin Nucl Med, 2011, 36: 183-185.
  • 52012年全国核医学现状普查简报[J].中华核医学与分子影像杂志,2012,32(5):357-357. 被引量:38
  • 6Shepherd TM, Idakoji IA, Pampaloni MH. Incidental detection of gastrointestinal stromal tumor by ^99Tc^m MDP bone scan[ J]. Clin Nucl Med, 2012, 37: 198-199.
  • 7Kawase T, Fujii H, Nakahara T, et al. Intense accumulation of ^99Tc^m MDP in pericardial metastasis from breast cancer [ J ]. Clin Nucl Med, 2009, 34: 173-174.
  • 8Martinez-Sanchis B, Cortes-Vizcaino V, Frontado-Morales L, et al. Intestinal uptake of ^99Tc^m-MDP : a case report of protein-losing en- teropathy correlated with pathology findings from autopsy [ J ]. Ann Nucl Med, 2011, 25: 139-141.
  • 9Bertagna F, Bosio G, Giubbini R. Incidental thyroid ^99Tc^m methyl- ene diphosphonate ( MDP ) uptake in a patient affected by polynod- ular goiter at bone scintigraphy[ J]. Nucl Med Rev Cent East Eur, 2009, 12: 81-82.
  • 10Codreanu I, Chamroonrat W, Cheng G, et al. Elevated MDP activ- ity in the spleen due to fungal infection[ J]. Clin Nucl Med, 2011, 36: 811-813.

二级参考文献25

  • 1季顺东,方纬,周俊东,何作祥,刘秀杰,阮长耿,赵明.新型凋亡显像剂^(99m)Tc-FM-2的制备及生物分布[J].核技术,2007,30(8):679-682. 被引量:2
  • 2邵虹,施美华,周莺,朱铭,吴靖川.骨显像和CT联合应用对儿童神经母细胞瘤临床分期的价值[J].中华核医学杂志,2004,24(4):227-228. 被引量:9
  • 3马超,匡安仁,李林,黄蕤,唐恭顺.恶性周围神经鞘膜瘤摄取骨显像剂一例[J].中华核医学杂志,2005,25(6):381-381. 被引量:4
  • 4Li C,Wang W,Wu Q,et al.Dual optical and nuclear imaging in human melanoma xenografts using a single targeted imaging probe.Nucl Med Biol,2006,33(3):349-358.
  • 5Kalevi K,Paola E,Kim B,et al.Nanoparticles in cancer.Current Radio,2008,1(1):30-36.
  • 6王志刚.多模态超声造影剂研究进展[J].中国医学影像技术,2010,26:221-221.
  • 7Townsend DW.Dual-modality imaging:combining anatomy and function.J Nucl Med,2008,49(6):938-955.
  • 8Hasegawa BH,Iwata K,Wong KH,et al.Dual-modality imaging of function and physiology.Acad Radiol,2002,9(11):1305-1321.
  • 9Bernd JP,Armin K,Thomas N,et al.PET/MRI:Paving the way for the next generation of clinical multimodality imaging applications.J Nucl Med,2010,51(3):333-336.
  • 10Cho ZH,Son YD,Kim HK,et al.A fusion PET-MRI system with a high-resolution research tomography-PET and ultra-high field 7.0T-MRI for the molecular-genetic imaging of the brain.Proteomics,2008,8(6):1302-1323.

共引文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部